Johnson and Johnson Case Analysis Essay example -- Business Marketing

Johnson and Johnson Case AnalysisIntroductionJohnson and Johnson, normally called J&J for short, is one of the worlds healthful known, bear-sizedst, some decentralized and just about diversified health care companies. Since 1887, Johnson and Johnson has been producing, manufacturing and selling products tie in to human health and well-being. Today J&J has over two hundred autonomous operating companies and do business globally specializing in consumer products, medical checkup devices and diagnostics, and pharmaceuticals. Consumer products are the companys most recognizable segment, including popular brands alike(p) Tylenol, Johnson and Johnson Baby Shampoo and Band-Aid. The medical devices and diagnostics segment manufactures products including surgical equipment and tactile sensation lenses. The largest of the three segments is pharmaceuticals. Johnson and Johnson is poised for increment on many fronts. Their short-term chance is bright due to a lead position in the do d rugs-coated stent market. They should overly see a substantial increase in prescription drug sales from the recently enacted Medicare regulation, which allow for grant prescription drug reportage to more Americans. In the long run, J&J should see concordant sales growth fueled by the aging demographics in the united States. Moreover, the medical supplies and services needed by the elderly population allow increase simultaneously with the aging of the large baby boomer population. patch there is no doubt that J&J is a heap that has gone a long way and due to its reliability, culture and growth will continue to do well, analyzing the strongness of their current strategy is muted essential. The question of whether J&J should break more centralized in order to adapt to the changing hospital industry needs to be addressed. Because of the changes in the hospital sector and because of the changes that distributors underwent in order to meet the hospital changes, J&J inevitably n eeds to change as well and become more centralized. While I do not see it is possible or even necessary for J&J to become completely centralized, J&J should consider the benefits of becoming more centralized. If J&J continues to be as decentralized as they are they will have a hard time adapting to change, communicating within the government and contact within the organization will decrease as well. In the recommendation portion of this case analysi... ... WeaknessWith regard to the internal environment, it is chief(prenominal) to analyze J&Js strengths and weakness. After reading J&Js website, I was overwhelmed with the strengths that J&J possess. J&J is one of the main competitors in the race to produce the best and most widely used stent. They produced Cypher, a device that is implanted in arteries to function keep arteries open and prevent them from getting clogged. J&J before long posses the largest portion of the coronary stent market with their Cypher stent. Approved in April of 2003 and launched in May, Cypher is the only drug-coated stent to be supported by numerous tests, including quaternary large-scale clinical trials involving 1,800 patients. In tests, Cypher proved more effective than bare metal stents at preventing re-blockage. Another strength that J&J possesses is having high barriers to entry. Entrance into the pharmaceutical industry is difficult. Pharmaceutical companies require large fixed costs, large set up costs and large question and development costs. While this does not insure that reinvigorated companies will not enter their market, it does give J&J some safety quantify at being able to prevent and/or compete with new entrants.